Acunpuncture for Fibromyalgia Syndrome

Acupuncture for Fibromyalgia Syndrome: An Observational Parallel Groups Study

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT04421521

Enrollment

Registered

2020-06-09

Start date

2020-07-01

Completion date

2021-05-01

Last updated

2020-06-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acupuncture, Fibromyalgia

Brief summary

patients suffering from fibromyalgia syndrome according to the criteria of the American College of Rheumatology 2010 will be enrolled. All fibromyalgic patients will be subjected to a further ambulatory visit and if an energy deficiency in the Liver and Spleen Meridians will be identified, according to the Traditional Chinese Medicine rules, acupuncture will be planned. If not, a standard therapy with analgesic drugs will be started. Acupuncture treatment will consist of six weekly sessions. Tricyclic antidepressants, anti-epileptic drugs, selective serotonin reuptake inhibitors and opioids will be used as standard strategy. Pain Scores and Fatigue Impact Scale will be assessed before any treatment and after a 28 days follow-up.

Interventions

PROCEDUREAcupuncture

Acupuncture with disposable needles will be implemented

Study design

Allocation

NON_RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to 75 Years

Healthy volunteers

Inclusion criteria

clinical diagnosis of Fibromyalgia

Exclusion criteria

coagulation disorders pregnancy pacemaker Implantable Cardioverter Defibrillator

Design outcomes

Primary

Measure	Time frame	Description
Pain Score	28 days after the completion of the treatment	Numeric Rating Scale from 0 (absence of pain )to 10 (worst pain )

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026